Zika NAT
Also Known as (Alias) | Zika Virus by Nucleic Acid Testing; Zika Virus RNA |
Indications | Blood Donor Screening, Living Donor Screening such as organ and tissue donation. Assay is not suitable for post-mortem samples. Assay is not intended for diagnostic use. |
Method | Roche cobas® Nucleic acid test for use on the cobas® 6800/8800 Systems Real Time PCR, Qualitative |
Test Information | The cobas® Zika test for use on the cobas® 6800 and cobas® 8800 Systems is a qualitative in vitro nucleic acid screening test for the direct detection of Zika virus RNA in human plasma. |
Sample Requirements | EDTA (Whole Blood) or Becton-Dickinson Plasma Preparation Tube |
Requested Volume | 6 ml |
Minimum Volume or Pediatric volume | 1 mL |
Sample Information | Dedicated EDTA tube. When a full 6 mL tube is submitted, may be combined with a request for Babesia-NAT and/or WNV-NAT |
Shipping Information | Samples collected in a plain EDTA tube are acceptable for 5 days at a combination of room temperature (up to 72 hours at ≤ 25°C) and at 2-8°C.
Acceptability is extended to a total of 7 days if sample is collected in a Becton-Dickinson Plasma Preparation Tube (PPT), and the PPT is centrifuged according to Becton-Dickenson centrifugation instructions prior to shipment of the sample. |
Requisition Form | Donor Testing RFT |
Transaction Code | 3078-25 |
Test Schedule | 7 days per week |
Turn around Time (analytic time) | 12 PM following day; STAT testing available for organ transplant testing |
Report/ Results | Negative, Positive, Unresolved |